Detalhe da pesquisa
1.
Higher frequency of comorbidities in fully vaccinated patients admitted to the ICU due to severe COVID-19: a prospective, multicentre, observational study.
Eur Respir J
; 59(2)2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34824059
2.
Activity of Antibiotics and Potential Antibiofilm Agents against Biofilm-Producing Mycobacterium avium-intracellulare Complex Causing Chronic Pulmonary Infections.
Antibiotics (Basel)
; 11(5)2022 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35625233
3.
Comparison of two-drug combinations, amikacin/tigecycline/imipenem and amikacin/tigecycline/clarithromycin against Mycobacteroides abscessus subsp. abscessus using the in vitro time-kill assay.
J Antibiot (Tokyo)
; 74(4): 285-290, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33420382
4.
In Vitro Activity of a Novel Quinolone, UB-8902, Against Ofloxacin-Resistant Mycobacterium tuberculosis Isolates.
Microb Drug Resist
; 26(9): 1019-1022, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32159449
5.
In vitro activity of 12 antimicrobial peptides against Mycobacterium tuberculosis and Mycobacterium avium clinical isolates.
J Med Microbiol
; 68(2): 211-215, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30570475
6.
Activity of 2-(quinolin-4-yloxy)acetamides in Mycobacterium tuberculosis clinical isolates and identification of their molecular target by whole-genome sequencing.
Int J Antimicrob Agents
; 51(3): 378-384, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28843821
7.
In Vitro Biofilm Formation in Mycobacterium avium-intracellulare Complex.
Arch Bronconeumol (Engl Ed)
; 57(2): 140-141, 2021 Feb.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-32943252
8.
In vitro time-kill curves study of three antituberculous combinations against Mycobacterium tuberculosis clinical isolates.
Int J Antimicrob Agents
; 47(1): 97-100, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26691020
9.
Mefloquine and its oxazolidine derivative compound are active against drug-resistant Mycobacterium tuberculosis strains and in a murine model of tuberculosis infection.
Int J Antimicrob Agents
; 48(2): 203-7, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27364701
10.
In vitro activity against Mycobacterium tuberculosis of levofloxacin, moxifloxacin and UB-8902 in combination with clofazimine and pretomanid.
Int J Antimicrob Agents
; 46(5): 582-5, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26421981